Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed360%
recruiting240%

Recent Activity

2 active trials
Showing 5 of 5
completednot_applicable

Studies in Patients With Defecatory Disorders

NCT03317938
recruitingnot_applicable

Fecobionics in Biofeedback Therapy in Dyssynergia Patients

NCT05807321
recruitingnot_applicable

Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)

NCT05412069
completednot_applicable

Trial to Evaluate Fecobionics in Healthy Subjects and Patients

NCT04766138
completednot_applicable

Studies in Patients With Low Anterior Resection Syndrome (LARS)

NCT03885999

Clinical Trials (5)

Showing 5 of 5 trials
NCT03317938Not Applicable

Studies in Patients With Defecatory Disorders

Completed
NCT05807321Not Applicable

Fecobionics in Biofeedback Therapy in Dyssynergia Patients

Recruiting
NCT05412069Not Applicable

Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)

Recruiting
NCT04766138Not Applicable

Trial to Evaluate Fecobionics in Healthy Subjects and Patients

Completed
NCT03885999Not Applicable

Studies in Patients With Low Anterior Resection Syndrome (LARS)

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5